Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of tumor-associated antigens with multi-cancer therapeutic potential.

Frontiers in immunology·2026
Same author

Activation of tumor-specific CD8+ T cells prior to radiopharmaceutical therapy improves antitumor response.

Journal for immunotherapy of cancer·2026
Same author

Overall Survival of Patients With PSA-Recurrent Prostate Cancer: Long-Term Analysis of a Randomized Phase 2 Trial of pTVG-HP DNA Vaccine Versus Placebo.

Clinical genitourinary cancer·2026
Same author

Spatially resolved single-cell landscape of tumor immunotypes reveals the central role of interferon signaling and plasmacytoid dendritic cells in triple-negative breast cancer.

Journal for immunotherapy of cancer·2026
Same author

Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Prognostic Significance, Predictive Value, and Emerging Directions for Clinical Implementation.

Cancers·2026
Same author

Plasmid DNA vaccines encapsulated in lipid nanoparticles elicit STING-dependent type 1 interferon release.

Molecular therapy. Advances·2026

Related Experiment Video

Updated: Jun 16, 2026

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase.

Brian M Olson1, Thomas P Frye, Laura E Johnson

  • 1Department of Medicine, University of Wisconsin, Madison, WI 53792, USA.

Cancer Immunology, Immunotherapy : CII
|February 9, 2010
PubMed
Summary

Researchers identified specific CD8+ T-cell epitopes for prostatic acid phosphatase (PAP) in prostate cancer patients. These PAP epitopes can monitor vaccine efficacy and potentially be used as vaccine antigens for immunotherapy.

More Related Videos

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
09:53

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein
08:04

Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein

Published on: December 20, 2017

Related Experiment Videos

Last Updated: Jun 16, 2026

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
09:53

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein
08:04

Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein

Published on: December 20, 2017

Area of Science:

  • Immunology
  • Oncology
  • Vaccinology

Background:

  • Prostatic acid phosphatase (PAP) is a target for prostate cancer vaccines.
  • Effective vaccines aim to induce PAP-specific CD8+ T cells.
  • Identifying T-cell epitopes is crucial for monitoring vaccine effectiveness and developing new antigens.

Purpose of the Study:

  • To identify PAP-specific CD8+ T-cell epitopes in HLA-A2+ individuals.
  • To validate these epitopes as targets for immunotherapy and monitoring.

Main Methods:

  • Screening of 11 PAP-derived nonamer peptides using ELISPOT assays.
  • Analysis of peripheral blood mononuclear cells from prostate cancer patients and healthy donors.
  • Confirmation of HLA-A2 restriction using CD8+ T-cell clones and DNA vaccine-immunized transgenic mice.

Main Results:

  • Three PAP peptides (p18-26, p112-120, p135-143) frequently elicited peptide-specific T cells.
  • CD8+ T-cell clones confirmed p18-26, p112-120, and p299-307 as HLA-A2-restricted epitopes.
  • Mice immunized with a PAP DNA vaccine showed epitope-specific responses.

Conclusions:

  • A method for identifying MHC class I-restricted epitopes by detecting pre-existing T-cell responses was established.
  • Identified PAP epitopes can serve as biomarkers for monitoring immune responses in patients receiving PAP-targeted vaccines.
  • These epitopes hold potential for developing novel vaccine antigens for prostate cancer immunotherapy.